Investing Profile

Jonathan Silverstein

VCInvestor
Executive Partner at OrbiMed
orbimed.comNew York, New York
Photo of Jonathan Silverstein, Partner at OrbiMed
cb
OrbiMed Partner
$1M - $75.0M
$4.0M
32
$18B
CompanyStageDateRound SizeTotal Raised
Aspen Neuroscience
Series BMay 2022$150M
Series AApr 2020$70M
SeedDec 2019$7M
$230M
Co-investors: Peter Thompson (OrbiMed), Doug Fisher (InterWest), Sam Altman
AcureX Therapeutics
GrantAug 2021
Co-investors: Brian Fiske (Flagship Ventures)
NeuroPace
Series UnknownAug 2020$33M
Series UnknownOct 2017$74M
$190M
Co-investors: James Blair (Domain Associates)
Prevail Therapeutics
Series BMar 2019$50M
Series AMar 2018$75M
$130M
resTORbio
Series ANov 2017$40M
$40M
Audentes Therapeutics
Series COct 2015$65M
Series BDec 2014$43M
Series AJul 2013$30M
$140M
Co-investors: Stephen Squinto (OrbiMed), Kush Parmar (5am Ventures), Jonathan Leff (Deerfield Management), Tom Woiwode (Versant Ventures)
Glaukos
Series FFeb 2013$30M
Series EFeb 2011$30M
Series DAug 2008$35M
$95M
Co-investors: Paul Madera (Meritech Capital Partners), Chau Khuong (OrbiMed), Bruce Cleveland (Wildcat Ventures), Gil Kliman (InterWest)
Relypsa
Series UnknownOct 2012$3M
Series CAug 2012$80M
Private EquityJul 2012$62M
Series BAug 2011$70M
Series BSep 2010$70M
$290M
Co-Founder The Silverstein Foundation for Parkinson's with GBA2017 - Present
Co-Head of Private Equity and General Partner OrbiMed Advisors1999 - Present
University of San Diego Doctor of Law (JD) and MBA
Denison University Bachelor's degree Economics